Identification and biological activities of a new antiangiogenic small molecule that suppresses mitochondrial reactive oxygen species

Biochemical and Biophysical Research Communications

Volumn 404, Issue 1, 2011, Pages 541-545

  Kim, Ki Hyun ^a   Park, Ju Yeol ^a   Jung, Hye Jin ^a   Kwon, Ho Jeong ^a  

^a Yonsei University   (South Korea)

Author keywords

Angiogenesis; Cell based screening; Mitochondrial ROS; YCG063

Indexed keywords

ANGIOGENESIS INHIBITOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; VASCULOTROPIN; YCG 063;

ANALYTICAL EQUIPMENT; ANGIOGENESIS; ARTICLE; CHORIOALLANTOIS; CONTROLLED STUDY; DRUG ACTIVITY; DRUG IDENTIFICATION; DRUG SCREENING; GENE TARGETING; HUMAN; HUMAN CELL; MITOCHONDRIAL RESPIRATION; MOLECULAR LIBRARY; PHENOTYPE; PRIORITY JOURNAL;

ANGIOGENESIS INHIBITORS; ANOXIA; CELL HYPOXIA; CELL LINE, TUMOR; CELLS, CULTURED; CHORIOALLANTOIC MEMBRANE; HUMANS; HYDRAZONES; MITOCHONDRIA; NEOVASCULARIZATION, PHYSIOLOGIC; NITROIMIDAZOLES; REACTIVE OXYGEN SPECIES; SMALL MOLECULE LIBRARIES;

EID: 78650908301     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.12.022     Document Type: Article

References (14)

1. Hamanaka R.B., Chandel N.S. Mitochondrial reactive oxygen species regulate hypoxic signaling. Curr. Opin. Cell Biol. 2009, 21:894-899.
2. Gerald D., Berra E., Frapart Y.M., Chan D.A., Giaccia A.J., Mansuy D., Pouyssegur J., Yaniv M., Mechta-Grigoriou F. JunD reduces tumor angiogenesis by protecting cells from oxidative stress. Cell 2004, 118:781-794.
3. Jung H.J., Shim J.S., Lee J., Song Y.M., Park K.C., Choi S.H., Kim N.D., Yoon J.H., Mungai P.T., Schumacker P.T., Kwon H.J. Terpestacin inhibits tumor angiogenesis by targeting UQCRB of mitochondrial complex III and suppressing hypoxia-induced reactive oxygen species production and cellular oxygen sensing. J. Biol. Chem. 2010, 285:11584-11595.
4. Bell E.L., Klimova T.A., Eisenbart J., Moraes C.T., Murphy M.P., Budinger G.R., Chandel N.S. The Qo site of the mitochondrial complex III is required for the transduction of hypoxic signaling via reactive oxygen species production. J. Cell Biol. 2007, 177:1029-1036.
5. Semenza G.L. Hypoxia, clonal selection, and the role of HIF-1 in tumor progression. Crit. Rev. Biochem. Mol. Biol. 2000, 35:71-103.
6. Brahimi-Horn M.C., Pouyssegur J. HIF at a glance. J. Cell Sci. 2009, 122:1055-1057.
7. Giuliano K.A. High-content profiling of drug-drug interactions: cellular targets involved in the modulation of microtubule drug action by the antifungal ketoconazole. J. Biomol. Screen. 2003, 8:125-135.
8. Gasparri F., Mariani M., Sola F., Galvani A. Quantification of the proliferation index of human dermal fibroblast cultures with the ArrayScan high-content screening reader. J. Biomol. Screen. 2004, 9:232-243.
9. Kim N.H., Pham N.B., Quinn R.J., Kwon H.J. R-(-)-beta-O-methylsynephrine, a natural product, inhibits VEGF-induced angiogenesis in vitro and in vivo. Biochem. Biophys. Res. Commun. 2010, 399:20-23.
10. Kim N.H., Jung H.J., Shibasaki F., Kwon H.J. NBBA, a synthetic small molecule, inhibits TNF-alpha-induced angiogenesis by suppressing the NF-kappaB signaling pathway. Biochem. Biophys. Res. Commun. 2010, 391:1500-1505.
11. Albini A., Iwamoto Y., Kleinman H.K., Martin G.R., Aaronson S.A., Kozlowski J.M., McEwan R.N. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res. 1987, 47:3239-3245.
12. Shim J.S., Kim J.H., Cho H.Y., Yum Y.N., Kim S.H., Park H.J., Shim B.S., Choi S.H., Kwon H.J. Irreversible inhibition of CD13/aminopeptidase N by the antiangiogenic agent curcumin. Chem. Biol. 2003, 10:695-704.
13. 2+/calmodulin antagonist HBC inhibits angiogenesis and down-regulates hypoxia-inducible factor. J. Biol. Chem. 2010, 285:25867-25874.
14. Kong X., Lin Z., Liang D., Fath D., Sang N., Caro J. Histone deacetylase inhibitors induce VHL and ubiquitin-independent proteasomal degradation of hypoxia-inducible factor 1alpha. Mol. Cell. Biol. 2006, 26:2019-2028.